Shanghai Kehua Bio-Engineering Co.,Ltd

XSEC:002022 Stock Report

Market Cap: CN¥3.3b

Shanghai Kehua Bio-EngineeringLtd Balance Sheet Health

Financial Health criteria checks 4/6

Shanghai Kehua Bio-EngineeringLtd has a total shareholder equity of CN¥4.7B and total debt of CN¥406.0M, which brings its debt-to-equity ratio to 8.6%. Its total assets and total liabilities are CN¥5.9B and CN¥1.2B respectively.

Key information

8.6%

Debt to equity ratio

CN¥406.03m

Debt

Interest coverage ration/a
CashCN¥1.02b
EquityCN¥4.75b
Total liabilitiesCN¥1.19b
Total assetsCN¥5.94b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 002022's short term assets (CN¥3.4B) exceed its short term liabilities (CN¥757.3M).

Long Term Liabilities: 002022's short term assets (CN¥3.4B) exceed its long term liabilities (CN¥436.5M).


Debt to Equity History and Analysis

Debt Level: 002022 has more cash than its total debt.

Reducing Debt: 002022's debt to equity ratio has reduced from 16.3% to 8.6% over the past 5 years.

Debt Coverage: 002022's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 002022's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies